Thoracic cancer data collection study
Treatments studied
Part of Blood & lymphatic, Cancer, Lungs & breathing clinical trials.
This study collects medical information from people with suspected or confirmed thoracic cancer. The goal is to learn more about these cancers and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed or strongly suspected cancer in the chest area (like lung cancer), based on tests and expert review.
- You must be able to understand the study and give your permission (informed consent) in writing or electronically.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
This study is a “specimen registry,” meaning it collects and stores samples from adults with chest (thoracic) diseases. It may help researchers better understand lung and chest conditions and improve future testing or treatments.
This study collects medical information and test results from people with lung cancer that has spread (or cannot be cured with local treatment). It does not test a new drug; it helps researchers better understand patients’ health and care needs over time.
This study collects medical data and samples from people with newly diagnosed bronchial cancer to learn more about the disease. You may be able to join if you have not yet started treatment for this cancer.
This study collects information about people who have been treated for lung or chest cancers at Lyon University Hospital. Your data may help researchers better understand these cancers and improve future care.
This study collects blood and tumor tissue samples from patients with certain untreated cancers to help researchers develop and improve tests. You may be eligible if you have one of the listed cancer types and have not yet started treatment.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.